中华消化外科杂志
中華消化外科雜誌
중화소화외과잡지
CHINESE JOURNAL OF DIGESTIVE SURGERY
2010年
1期
35-37
,共3页
郑树国%李建伟%陈健%范毓东%揭中芳%马宽生%王曙光%别平
鄭樹國%李建偉%陳健%範毓東%揭中芳%馬寬生%王曙光%彆平
정수국%리건위%진건%범육동%게중방%마관생%왕서광%별평
肝肿瘤%腹腔镜检查%肝切除术%导管消融术,射频
肝腫瘤%腹腔鏡檢查%肝切除術%導管消融術,射頻
간종류%복강경검사%간절제술%도관소융술,사빈
Liver neoplasms%Laparoscopes%Hepatectomy%Catheter ablation,radiofrequency
目的 探讨腹腔镜手术治疗肝癌的临床价值.方法 回顾性分析2007年3月至2009年10月第三军医大学西南医院采用腹腔镜手术治疗128例肝癌患者的临床资料.其中原发性肝癌116例,转移性肝癌12例.行腹腔镜肝切除术107例,单纯腹腔镜下RFA治疗15例,腹腔镜下门静脉右支结扎降期治疗6例.结果 107例行腹腔镜肝切除术患者中7例中转开腹手术,5例中转手助式腹腔镜肝切除术.规则性肝切除88例,包括左外叶切除21例、左半肝切除15例、超左半肝切除2例、中肝切除1例、右半肝切除11例、右后叶切除9例、单肝段切除29例;两个以上部位联合切除4例;非规则性肝切除15例.肝切除术的平均手术时间(228±92)min,术中平均出血量(393±213)ml,无手术死亡,16例术后出现并发症,术后平均住院时间(8±4)d.126例患者随访1~42个月,12例行腹腔镜肝切除术者于术后3~16个月死亡,术后平均生存时间(118±7)周,平均无瘤生存时间(105±7)周.行腹腔镜下BFA治疗的2例患者分别于术后9个月及11个月死亡;行腹腔镜下门静脉结扎的2例患者于术后行二期根治性切除.结论 腹腔镜手术治疗肝癌安全可行,具有创伤小、恢复快的优点.
目的 探討腹腔鏡手術治療肝癌的臨床價值.方法 迴顧性分析2007年3月至2009年10月第三軍醫大學西南醫院採用腹腔鏡手術治療128例肝癌患者的臨床資料.其中原髮性肝癌116例,轉移性肝癌12例.行腹腔鏡肝切除術107例,單純腹腔鏡下RFA治療15例,腹腔鏡下門靜脈右支結扎降期治療6例.結果 107例行腹腔鏡肝切除術患者中7例中轉開腹手術,5例中轉手助式腹腔鏡肝切除術.規則性肝切除88例,包括左外葉切除21例、左半肝切除15例、超左半肝切除2例、中肝切除1例、右半肝切除11例、右後葉切除9例、單肝段切除29例;兩箇以上部位聯閤切除4例;非規則性肝切除15例.肝切除術的平均手術時間(228±92)min,術中平均齣血量(393±213)ml,無手術死亡,16例術後齣現併髮癥,術後平均住院時間(8±4)d.126例患者隨訪1~42箇月,12例行腹腔鏡肝切除術者于術後3~16箇月死亡,術後平均生存時間(118±7)週,平均無瘤生存時間(105±7)週.行腹腔鏡下BFA治療的2例患者分彆于術後9箇月及11箇月死亡;行腹腔鏡下門靜脈結扎的2例患者于術後行二期根治性切除.結論 腹腔鏡手術治療肝癌安全可行,具有創傷小、恢複快的優點.
목적 탐토복강경수술치료간암적림상개치.방법 회고성분석2007년3월지2009년10월제삼군의대학서남의원채용복강경수술치료128례간암환자적림상자료.기중원발성간암116례,전이성간암12례.행복강경간절제술107례,단순복강경하RFA치료15례,복강경하문정맥우지결찰강기치료6례.결과 107례행복강경간절제술환자중7례중전개복수술,5례중전수조식복강경간절제술.규칙성간절제88례,포괄좌외협절제21례、좌반간절제15례、초좌반간절제2례、중간절제1례、우반간절제11례、우후협절제9례、단간단절제29례;량개이상부위연합절제4례;비규칙성간절제15례.간절제술적평균수술시간(228±92)min,술중평균출혈량(393±213)ml,무수술사망,16례술후출현병발증,술후평균주원시간(8±4)d.126례환자수방1~42개월,12례행복강경간절제술자우술후3~16개월사망,술후평균생존시간(118±7)주,평균무류생존시간(105±7)주.행복강경하BFA치료적2례환자분별우술후9개월급11개월사망;행복강경하문정맥결찰적2례환자우술후행이기근치성절제.결론 복강경수술치료간암안전가행,구유창상소、회복쾌적우점.
Objective To investigate the value of laparoscopy in the treatment of liver cancer.Methods The clinical data of 128 liver cancer patients who received laparoscopic surgery at Southwest Hospital from March 2007 to October 2009 were retrospectively analyzed.Of all patients,116 were with primary liver cancer,and 12 with metastatic liver cancer.There were 107 patients who received laparoscopie bepatectomy,15 received laparoscopic radiofrequency ablation(RFA)and 6 received laparoscopic ligation of the right branch of portal vein.Results Of the 107 patients who received laparoscopic bepatectomy,7 were converted to open surgery,and 5 were converted to hand-assisted laparoscopic hepatectomy.Anatomical hepatectomy was performed on 88 patients,including left lateral lobectomy on 21,left hemihepatectomy on 15,extended left hemihepatectomy on 2,medial lobectomy on 1,right hemihepatectomy on 11,right posterior lobeetomy on 9 and hepatic segmentectomy on 29.Combined hepatic resection was performed on 4 patients,and nonanatomical hepatectomy on 15.The mean oporatire time and blood loss were(228±92)minutes and(393±213)ml,with no operative mortality.The mean postoperative hospital stay was(8±4)days,and the incidence of complications was 15%(16/107).A total of 126 patients were followed up for 1-42 months,12 patients with laparoscopic hepatectomy died within 16 months,with the mean survival time of(118±7)weeks and the mean tumor free survival time of(105±7)weeks;2 patients with laparoscopic RFA died within 11 months:2 patients with laparoseopie ligation of the right branch of portal vein received two-stage radical resection.Conclusion Laparoscopic surgery is safe and feasible with the advantages of minimal operative trauma and quick recovery of patients when it is applied to the treatment of liver cancer.